ANVS vs LRCX · $80.4M cap vs P/E 71, rev $23.23B
Annovis Bio Inc (ANVS) versus Lam Research Corp (LRCX) — a side-by-side from cached financials, not a winner call.
Annovis Bio Inc (ANVS) is a biotechnology company listed on US.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ. It is led by Timothy M. Archer.
Latest reported ANVS revenue for 2026-06-30 was $0. Net income was -$32.4M. ANVS currently screens at market cap $80.4M.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
ANVS currently screens at market cap $80.4M. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Not investment advice. Open the ANVS and LRCX stock pages for the full models.
Not investment advice.